KBS Corporate Finance Advises on the Sale of Zeta Analytics Ltd
Zeta Analytics Ltd is an established and trusted provider of independent testing for licensed human, veterinary and medical products, working with prestigious, multinational clients in the pharmaceutical sector.
Zeta Analytics Ltd is an established and trusted provider of independent testing for licensed human, veterinary and medical products, working with prestigious, multinational clients in the pharmaceutical sector. The Company has experienced considerable growth since its inception, with its reputation for providing exceptional service, a knowledgeable workforce and high-quality solutions ensuring its continued strength. Zeta Analytics operates internationally, working with several blue-chip pharmaceutical companies and benefitting from a high volume of repeat custom.
The opportunity attracted 64 interested parties predominately from UK trade. These high levels of interest produced four offers.
The successful offer came from Phenna Group, which previously acquired The IASME Consortium Ltd via KBS Corporate Finance in September 2021.
Mayur Gohil, MD of Zeta Analytical commented, “I am very excited for Zeta Analytical to join Phenna Group at an important time in my company’s history. Our business has developed over many years, underpinned by strong family values, and so selecting the right partner who appreciated and understood our operating model was important. Phenna and Zeta have a like-minded philosophy and that was key in my decision-making. Since my first call with Paul and the Phenna Team, they have been easy to deal with, acting with integrity throughout. I believe the business is in great hands for the future ambitions we have. Zeta shares Phenna’s value of trust and allowing Zeta to operate with a high level of autonomy”.
Paul Barry, Group CEO of Phenna Group said, “I am pleased and excited to welcome Mayur and the wider Zeta team to Phenna Group. Zeta is an excellent and experienced team and from our first meeting with Mayur, I was convinced they would be a great fit within our Group. Adding additional services and capacity to our Health Sciences Division has been a key strategic objective for the Group. I very much look forward to working with Mayur and his team to help deliver their ambitious growth plans.”
Tom Eatough, Corporate Director at KBS Corporate Finance, advised Zeta Analytics throughout the process.